Head-to-head · Cost-Efficiency Index
Wisp vs GobyMeds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Wisp
Cost-first shoppers who want branded injectables plus a sublingual semaglutide alternative.
Visit WispGobyMeds
Shoppers comfortable prepaying a 3-month bundle upfront to get the lowest advertised compounded GLP-1 rate.
Visit GobyMedsThe verdict
Wisp takes it, leading the Cost-Efficiency Index 63 to 62. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. GobyMeds still earns a C — Shoppers comfortable prepaying a 3-month bundle upfront to get the lowest advertised compounded GLP-1 rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Wisp.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Wisp | GobyMeds |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 62/100 |
| Semaglutide / mo | $225/mo (compounded oral) | $99/mo (starting dose, 3-month plan, compounded) |
| Tirzepatide / mo | Not disclosed | $133/mo (starting dose, 3-month plan, compounded) |
| Semaglutide / yr (modeled) | $2,700 | $1,188 |
| Tirzepatide / yr (modeled) | — | $1,596 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #202 | #207 |
Wisp
63/100Where the value is
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
The tradeoffs
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
GobyMeds
62/100Where the value is
- Available in all 50 states per the site's own copy
- No membership fees, free shipping, and HSA/FSA accepted
- Transparent tiered pricing published before intake, including how bundle cost rises with dose reached
The tradeoffs
- The $99/$133 headline requires prepaying the full 3-month bundle ($299/$399); paying monthly costs $169/$299 instead — 71% to 125% more
- Compounding pharmacy is not named, only described as 'GobyMeds' 503A or 503B pharmacy partner'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.